Zidovudine

CAS 30516-87-1 7 current records 11 historicalSmall Molecule

Who holds supplier records for Zidovudine? 7 organisations hold a current record for Zidovudine: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5) and China (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Zidovudine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zidovudine

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Zidovudine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Zidovudine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Zidovudine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2007-318 - Rev 07
Zidovudine
Sept 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2008-333 - Rev 07
Zidovudine
May 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2005-063 - Rev 05
Zidovudine
Nov 2023—
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang TownCN
R0-CEP 2021-015 - Rev 00
Zidovudine
Jul 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (11)

Organisations whose Type II DMFs for Zidovudine are no longer active. These show a past filing, not current supply.

Show all 11 historical records
  • Zhejiang Langhua Pharmaceutical Co. Ltd.
    China · Inactive DMF 26695 · filed Oct 2012
  • MATRIX PHARMA GROUP XIAMEN LTD
    Inactive DMF 25082 · filed Jun 2011
  • MYLAN LABORATORIES LTD
    Inactive DMF 24450, 24550 · filed Dec 2010
  • India · Inactive DMF 21570 · filed Apr 2008
  • SIBRA PHARMACEUTICALS LTD AN ARCH ENTERPRISE
    Inactive DMF 21325 · filed Feb 2008
  • RANBAXY LABORATORIES LTD
    Inactive DMF 20703 · filed Jul 2007
  • MATRIX LABORATORIES LTD
    Inactive DMF 17952 · filed Dec 2004
  • South Korea · Inactive DMF 13181 · filed Sept 1998
  • ESTEVE QUIMICA SA
    Inactive DMF 10866 · filed Apr 1994
  • HOUBA INC
    Inactive DMF 9712 · filed Jun 1992
  • SIGNA SA DE CV
    Inactive DMF 8818 · filed Nov 1990

Overview

Zidovudine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL129).

Chemical identity

IUPAC name
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Canonical SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
InChIKey
HBOMLICNUCNMMY-XLPZGREQSA-N
Synonyms
3'-azt, Azidothymidine, AZT, BW A509U, BW-A-509U, BW-A509U, Bwa509u, COMPOUND S, COMPOUND-S, NSC-602670, Retrovir, Zidovudina

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Mechanism of action
Nucleoside Reverse Transcriptase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Zidovudine?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Zidovudine: APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Shanghai Desano Chemical Pharmaceutical Co., Ltd (China), Cipla Limited (India), SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD (China) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Zidovudine Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 17638, 18714), Hetero Labs Limited (DMF 18291, 24608), MATRIX PHARMACORP PRIVATE LTD (DMF 17751), Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 21277), Cipla Limited (DMF 16677), SHANGHAI SHYNDEC PHARMACEUTICAL HAIMEN CO LTD (DMF 27207) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 25009). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Zidovudine records mean?

11 organisations have only inactive Type II DMFs for Zidovudine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Zidovudine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Zidovudine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), HETERO LABS LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Zidovudine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Zidovudine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.